NewAmsterdam Pharma Co N.V. (NAMS) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.72 | +32.8% |
| 2024 | $-2.56 | -19.1% |
| 2023 | $-2.15 | -80.7% |
| 2022 | $-1.19 | +68.8% |
| 2021 | $-3.81 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.72 | +32.8% |
| 2024 | $-2.56 | -19.1% |
| 2023 | $-2.15 | -80.7% |
| 2022 | $-1.19 | +68.8% |
| 2021 | $-3.81 | — |